| # | Drug | Count |
|---|---|---|
| 0 | CEFTRIAXONE SODIUM | 103 |
| 1 | CEFTRIAXONE | 78 |
| 2 | PREDNISOLONE | 5 |
| 3 | PREDNISOLONE ORAL | 5 |
| 4 | PREDNISOLONE ORAL SOLUTION | 5 |
| 5 | FUROSEMIDE | 3 |
| 6 | METRONIDAZOLE | 3 |
| 7 | METRONIDAZOLE TOPICAL | 3 |
| 8 | ATOVAQUONE | 2 |
| 9 | ATOVAQUONE ORAL SUSPENSION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 1 | CEFTRIAXONE SODIUM | 103 | 0.0026 |
| 2 | CHLORPROMAZINE HYDROCHLORIDE | 1 | 0.0010 |
| 3 | CABOTEGRAVIR SODIUM | 1 | 0.0006 |
| 4 | DAPRODUSTAT | 1 | 0.0005 |
| 5 | RASBURICASE | 1 | 0.0004 |
| 6 | ETHAMBUTOL HYDROCHLORIDE | 1 | 0.0004 |
| 7 | RIFABUTIN | 1 | 0.0004 |
| 8 | LEMBOREXANT | 1 | 0.0003 |
| 9 | HYDROXYZINE PAMOATE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 5 |
| 1 | Loop Diuretic [EPC] | 4 |
| 2 | Nitroimidazole Antimicrobial [EPC] | 3 |
| 3 | Antimalarial [EPC] | 2 |
| 4 | Antiprotozoal [EPC] | 2 |
| 5 | Azole Antifungal [EPC] | 2 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 2 |
| 7 | Macrolide Antimicrobial [EPC] | 2 |
| 8 | Proton Pump Inhibitor [EPC] | 2 |
| 9 | Aldosterone Antagonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 3 | Antimalarial [EPC] | 2 | 0.0002 |
| 4 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 5 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 7 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 3 | 0.0000 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |